Clinical Evidence of Inflammation in PAH: A Case Study of Profibrotic Macrophages - Dr. Jane A. Leopold

All credits: Dr. Jane A. Leopold, Brigham and Women's Hospital and Harvard Medical School

A Conference Talk by:Dr. Jane A. Leopold, Brigham and Women's Hospital and Harvard Medical SchoolPresented at: 8th PVRI Annual World Congress, Guangzhou, China.

Additional keywords: inflammation,biomarkers,scleroderma,CRP,IL6

About the author

Jane Leopold

Director, Women's Interventional Cardiology Health Initiative

Brigham and Women's Hospital

United States

Clinical Evidence of Inflammation in PAH: A Case Study of Profibrotic Macrophages - Dr. Jane A. Leopold

About the author

Jane Leopold

More from this author

Our research platform is the world.

About the author

Jane Leopold

More from this author

Related Content

{{GlobalController.truncateTitle("Focusing on Inflammation and Immune Modification to Treat PH", 65)}}

{{GlobalController.truncateTitle("Role of Mesenchymal Cell-Macrophage Interactions in the Development of Pulmonary Vascular Remodeling and Hypertension - Dr. Kurt R. Stenmark", 65)}}

{{GlobalController.truncateTitle("An atypical presentation of adult-onset Still’s disease complicated by pulmonary hypertension and macrophage activation syndrome treated with immunosuppression: a case-based review of the literature", 65)}}

{{GlobalController.truncateTitle("Animal models of pulmonary hypertension are consistently characterized by adventitial/peri-vascular accumulation of leukocytes, and in particular mononuclear cells", 65)}}

{{GlobalController.truncateTitle("Tuning Nrf2 stress response to enhance host defense in COPD", 65)}}

Add to reading list

Share this content

Our research platform is the world.